Psychedelics remain illegal for recreational use in New Hampshire as of 2026, but the state’s legal framework is shifting. While psilocybin mushrooms, LSD, and MDMA are still classified as Schedule I controlled substances under New Hampshire law, recent legislative initiatives and research pilots suggest a nuanced future. In 2024 the New Hampshire General Court introduced a bill to de‑criminalize personal possession of small amounts of psilocybin, and a 2025 pilot program authorized two hospitals to administer psilocybin in clinical trials for treatment‑resistant depression. These developments, however, have not yet altered the statutory prohibitions that carry penalties ranging from fines to imprisonment. Consequently, anyone caught with psychedelics in the state can still face criminal charges, although prosecutors are increasingly exercising discretion for low‑level offenses.
Current Legal Landscape
Under RSA 225‑1 and RSA 225‑2, psilocybin, LSD, DMT, and related compounds are listed as Schedule I substances, meaning they are deemed to have no accepted medical use and a high potential for abuse. Possession of any amount is a misdemeanor punishable by up to one year in jail and a $2,000 fine, while intent to sell triggers felony charges. Law enforcement agencies continue to treat psychedelics as controlled substances, and no statewide de‑criminalization has been enacted.
Legislative Efforts
The 2024 “Psychedelic Reform Act” failed to achieve a majority vote but sparked bipartisan dialogue. In 2025 a compromise bill passed, creating a “low‑level offense” category that redirects first‑time offenders to education and treatment rather than incarceration. This approach mirrors Oregon’s Measure 109 but stops short of legalizing possession. Proponents argue that de‑criminalization would reduce court burdens and align with emerging scientific evidence; opponents cite concerns about public safety and the lack of robust regulatory frameworks.
Medical Use and Research
New Hampshire’s Department of Health and Human Services granted a conditional license to Dartmouth‑Hitchcock Medical Center and the University of New Hampshire for a two‑year psilocybin‑assisted therapy trial. The study, approved by the FDA under an IND application, investigates efficacy for major depressive disorder and PTSD. Participants receive doses in a controlled setting, and the program operates under strict oversight. While the trial may pave the way for future therapeutic pathways, it does not change the legal status of psilocybin for the general public.
Future Outlook
Experts predict that by 2028 New Hampshire could join a growing number of states experimenting with regulated psychedelic medicine. Ongoing public opinion polls show that 58 % of residents support de‑criminalizing personal use of psilocybin, reflecting a national trend toward liberalization. However, any shift will require legislative action, federal scheduling changes, and sustained advocacy. Until then, possession and distribution remain prosecutable offenses.
FAQ
What penalties apply for first‑time possession of psilocybin in New Hampshire?
First‑time possession is treated as a misdemeanor, carrying up to one year in jail and a $2,000 fine, though judges may elect diversion to education under the 2025 low‑level offense provision.
Can doctors prescribe psychedelics for mental‑health treatment?
No. Only federally approved research protocols, such as the Dartmouth‑Hitchcock trial, permit administration of psychedelics. Prescription outside these studies remains illegal.
Are there any cities in New Hampshire that have de‑criminalized psychedelics?
As of 2026, no municipality in the state has enacted local ordinances to de‑criminalize psychedelics; all jurisdictions follow state law.
How does New Hampshire’s stance compare to neighboring states?
Maine and Vermont also classify psychedelics as Schedule I, though Maine’s legislature has introduced a de‑criminalization bill. Massachusetts has not pursued similar measures, keeping a stricter enforcement posture.
What should someone do if they are charged with a psychedelic‑related offense?
Seek counsel from an attorney experienced in New Hampshire drug law. Early engagement can open possibilities for diversion programs or reduced sentencing under the low‑level offense framework.